DG
Daniil Gataulin Chardan Capital Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
77
Avg Return
Past Year
Past Year
18%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past 3 Months
Positive
84%
Neutral
16%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - General
Stock | Rating | Price Target |
Upside Downside |
Ratings 3 Months |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
---|---|---|---|---|---|---|---|---|
Buy
Initiated
| $9 |
355%
upside
| 1 | -0.5% |
0
%
| 16 Oct ‘25 4 days ago |
|
|
Buy
Maintained
| $51 |
134%
upside
| 1 | +4.5% |
0
%
| 8 Oct ‘25 12 days ago |
|
|
Neutral
Maintained
| $14 |
21%
downside
| 1 | – |
–
| 6 Oct ‘25 14 days ago |
|
|
Buy
Maintained
| $21 |
72%
upside
| 2 | -1.8% |
0
%
| 2 Oct ‘25 18 days ago |
|
|
Buy
Maintained
| $10 |
197%
upside
| 2 | +43% |
0
%
| 30 Sep ‘25 20 days ago |
|
|
Buy
Maintained
| $76 |
19%
upside
| 4 | +33% |
0
%
| 25 Sep ‘25 25 days ago |
|
|
Buy
Maintained
| $7 |
332%
upside
| 2 | +7.1% |
0
%
| 19 Sep ‘25 1 month ago |
|
|
Neutral
Downgraded
| $48 |
0%
upside
| 2 | +48% |
0
%
| 10 Sep ‘25 1 month ago |
|
|
Buy
Maintained
| $52 |
311%
upside
| 2 | +5.5% |
0
%
| 8 Sep ‘25 1 month ago |
|
|
Neutral
Maintained
| $3 |
103%
upside
| 2 | – |
–
| 28 Aug ‘25 1 month ago |
|
|
Buy
Maintained
| $61 |
400%
upside
| 1 | +65% |
0
%
| 15 Aug ‘25 2 months ago |
|
|
Buy
Maintained
| $35 |
325%
upside
| 1 | +11% |
0
%
| 15 Aug ‘25 2 months ago |
|
|
Buy
Maintained
| $33 |
640%
upside
| 1 | +23% |
0
%
| 13 Aug ‘25 2 months ago |
|
|
Buy
Maintained
| $15 |
100%
upside
| 1 | -9.7% |
0
%
| 11 Aug ‘25 2 months ago |
|
|
Buy
Maintained
| $4 |
119%
upside
| 1 | +32% |
0
%
| 8 Aug ‘25 2 months ago |
|
|
Buy
Maintained
| $27 |
124%
upside
| 1 | +4.5% |
0
%
| 7 Aug ‘25 2 months ago |
|